Baseline CSF tau and short-term clinical change during lecanemab therapy: A prospective real-world cohort study in Japan. (PubMed, Alzheimers Dement (Amst)) - Oct 2, 2026 - "Baseline CSF pTau181 and total tau were associated with 6-month clinical trajectories, supporting cautious cohort-level risk stratification."
Journal • Real-world evidence • Alzheimer's Disease • CNS Disorders • Dementia • APOE • Aβ42 • CSF P-tau • p-tau181
|
|
Akira Hashiramoto; Eiji Mizuta; Hisatomo Kowa; Jun Fujita; Kohsuke Yoshida; Ryuichi Takahashi; Tetsuo Kashibayashi
|